1 |
10-mg dose of e5501 cyclodextrin oral solution |
- |
- |
- |
- |
063 [1] 63 💬 |
2 |
10-mg dose of e5501 lipid-based oral |
- |
- |
- |
- |
063 [1] 63 💬 |
3 |
2% chlorhexidine solution wipes |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
4 |
20 mg sildenafil citrate by mouth |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
5 |
4% chlorhexidine gluconate liquid skin cleanser |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
6 |
5% sildenafil cream |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
050 [1] 50 💬 |
7 |
750 mg metformin and 7.5 g l-citrulline daily p.o. |
Citrulline |
[3] D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 [1] 113 💬 |
8 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
9 |
A novel synthetic, orally-administered, non-peptide small molecule, which acts as |
- |
- |
- |
- |
254 [1] 254 💬 |
10 |
Access program - sildenafil citrate, viagra, revatio |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
11 |
Acetohydroxamic acid oral tablet [lithostat] |
Acetohydroxamic acid |
[1] D00220 D00220 💬 |
- |
- |
251 [1] 251 💬 |
12 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 [1] 86 💬 |
13 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
14 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
15 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
16 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
17 |
All subjects will receive maraviroc 300mg orally twice a day for 6 weeks |
Maraviroc |
[1] D06670 D06670 💬 |
CCR5 [1] CCR5 💬 |
Chemokine signaling pathway [9] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
084 [1] 84 💬 |
18 |
Alvelestat oral tablet - dose 1 |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
19 |
Alvelestat oral tablet - dose 2 |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
20 |
Amifampridine phosphate 10 mg oral tablet |
Amifampridine |
[1] D10228 D10228 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [1] 3 💬 |
21 |
Amt-101 (oral) |
- |
- |
- |
- |
097 [1] 97 💬 |
22 |
Anavex2-73 oral liquid |
- |
- |
- |
- |
156 [1] 156 💬 |
23 |
Antihistamine (cetirizine or equivalent) |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
24 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
25 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
26 |
Azd4017 and prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
27 |
Azp2006 oral solution |
- |
- |
- |
- |
005 [1] 5 💬 |
28 |
Bardoxolone methyl oral capsule |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
29 |
Bladder instillation with triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
226 [1] 226 💬 |
30 |
Bladder instillation without triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
226 [1] 226 💬 |
31 |
Bosentan and sildenafil |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
32 |
Budesonide oral suspension |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
33 |
Budesonide oral suspension [0.2 mg/ml] |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
34 |
Cannabidiol oral solution |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
140 [4] 140, 144, 145, 193 💬 |
35 |
Carbidopa 200mg oral dose |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
36 |
Carbidopa-levodopa 25 mg-100 mg oral tablet |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
37 |
Cbd - oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
140 [3] 140, 144, 158 💬 |
38 |
Cbd - oral solution, is known as epidyolex, and is the approved name |
- |
- |
- |
- |
156 [1] 156 💬 |
39 |
Cbd oral solution, is known as epidyolex and is the approved name in the eu |
- |
- |
- |
- |
156 [1] 156 💬 |
40 |
Cbd-oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
158 [1] 158 💬 |
41 |
Cephalexin |
Cephalexin |
[2] D00263 D00263, D00906 D00906 💬 |
- |
- |
299 [1] 299 💬 |
42 |
Cetirizine |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [2] 13, 35 💬 |
43 |
Cetirizine hydrochloride |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
44 |
Chlorhexidine |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 [2] 86, 299 💬 |
45 |
Chlorhexidine gluconate |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
46 |
Chlorhexidine gluconate oral rinse |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
47 |
Cialis - 20 mg 2 compresse rivestite con film in blister uso orale |
- |
- |
- |
- |
075 [1] 75 💬 |
48 |
Cladribina oral |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
49 |
Cladribine oral tablet |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
50 |
Cohort 1:nilotinib oral capsules (150mg or 300mg) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
51 |
Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
52 |
Colchicine 1 mg oral tablet |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [1] 2 💬 |
53 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
[2] D00088 D00088, D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
54 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
[9] D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT [2] ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
55 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
56 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
57 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
064 [1] 64 💬 |
58 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
59 |
Cosyntropin injectable suspension 1 mg/ml + vigabatrin |
Tetracosactide |
[2] D00284 D00284, D00535 D00535 💬 |
ABAT [2] ABAT, MC2R 💬 |
Alanine, aspartate and glutamate metabolism [12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway |
145 [1] 145 💬 |
60 |
Cultivated oral mucosal epithelial sheet transplantation |
- |
- |
- |
- |
038 [2] 38, 162 💬 |
61 |
Cx-4945 oral formulation |
- |
- |
- |
- |
331 [1] 331 💬 |
62 |
Cyclophosphamide 50mg oral tablet |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
162 [1] 162 💬 |
63 |
Cyclosporine oral product |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
64 |
Deferasirox |
Deferasirox |
[1] D03669 D03669 💬 |
- |
- |
254 [3] 254, 284, 286 💬 |
65 |
Deferiprone 80 mg/ml oral solution |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
120 [1] 120 💬 |
66 |
Deferiprone 80 mg/ml oral solution (ferriprox) |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
120 [1] 120 💬 |
67 |
Deferiprone oral solution |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
120 [1] 120 💬 |
68 |
Desmopressin oral melt |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
69 |
Deutetrabenazine oral tablet [austedo] |
Deutetrabenazine |
[1] D10701 D10701 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
70 |
Device: frequently sampled oral glucose tolerance test and cgm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
71 |
Device: home oral glucose tolerance test kit |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
72 |
Device: iowa oral performance instrument |
- |
- |
- |
- |
002 [1] 2 💬 |
73 |
Device: iowa oral pressure instrument |
- |
- |
- |
- |
002 [1] 2 💬 |
74 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
75 |
Diagnostic test: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
013 [3] 13, 65, 299 💬 |
76 |
Dronabinol 25 mg/ml, oral drops |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
77 |
Duo-therapy with sildenafil + bosentan |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
78 |
E5501 40 mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 [1] 63 💬 |
79 |
E5501 40 mg 2 x 20-mg tablets, orally, with food |
- |
- |
- |
- |
063 [1] 63 💬 |
80 |
E5501 40mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 [1] 63 💬 |
81 |
Eltrombopag oral tablets |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
82 |
Entacapone 400mg oral dose |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
83 |
Enterabio's oral parathyroid hormone (1-34) |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
84 |
Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) |
Bosentan |
[6] D01227 D01227, D02008 D02008, D02229 D02229, D07538 D07538, D08514 D08514, D10135 D10135 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
85 |
Erythrocine oral |
- |
- |
- |
- |
036 [1] 36 💬 |
86 |
Etanercept, methotrexate, prednisolone |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 [1] 56 💬 |
87 |
Everolimus oral product |
Everolimus |
[1] D02714 D02714 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [2] 89, 158 💬 |
88 |
Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) |
- |
- |
- |
- |
013 [1] 13 💬 |
89 |
Fentanyl |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [4] 46, 70, 215, 231 💬 |
90 |
Fentanyl (high dose) |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 [1] 215 💬 |
91 |
Fentanyl (low dose) |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 [1] 215 💬 |
92 |
Fentanyl (low dose) + dexmedetomidine |
Dexmedetomidine |
[4] D00320 D00320, D00514 D00514, D01205 D01205, D01399 D01399 💬 |
ADRA2A [4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 |
Estrogen signaling pathway [4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
93 |
Fentanyl transdermal patch |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
94 |
Ferrous sulphate 200mg oral tablet |
- |
- |
- |
- |
227 [1] 227 💬 |
95 |
Fipamezole hydrochloride 30 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
96 |
Fipamezole hydrochloride 60 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
97 |
Fipamezole hydrochloride 90 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
98 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 [1] 11 💬 |
99 |
Flucloxacillin 250mg/5ml sugar-free powder for oral solution |
Flucloxacillin |
[3] D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 [1] 299 💬 |
100 |
Flx-787-odt (orally disintegrating tablet) |
- |
- |
- |
- |
010 [1] 10 💬 |
101 |
Flx-787-odt (orally disintigrating tablet) |
- |
- |
- |
- |
002 [1] 2 💬 |
102 |
Fmt oral |
- |
- |
- |
- |
097 [1] 97 💬 |
103 |
G04be03- sildenafil - sildenafil (citrato) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
104 |
Glatiramer acetate injection with oral cetirizine hydrochloride |
Acetate |
[3] D00664 D00664, D04318 D04318, D07662 D07662 💬 |
HLA-A [21] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 |
Allograft rejection [35] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
105 |
Glpg0259 oral capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
106 |
Glucocorticoid (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
107 |
Glucophage (metformin) |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [2] 46, 75 💬 |
108 |
Ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [6] 13, 46, 65, 113, 271, 299 💬 |
109 |
Ibuprofen 200mg |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
110 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
111 |
Idl-2965 oral capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
112 |
Ins1007 10 mg oral tablet |
- |
- |
- |
- |
299 [1] 299 💬 |
113 |
Ins1007 25 mg oral tablet |
- |
- |
- |
- |
299 [1] 299 💬 |
114 |
Interferon alpha oral lozenge |
- |
- |
- |
- |
085 [1] 85 💬 |
115 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
[6] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
116 |
Intra plexus triamcinolone and bupivicaine injection |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
117 |
Intravenous and oral n-acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [1] 6 💬 |
118 |
Intravenous methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
119 |
Iohexol |
Iohexol |
[1] D01817 D01817 💬 |
- |
- |
019 [2] 19, 67 💬 |
120 |
Iohexol inj 300 milligrams per milliliter (mg/ml) |
Iohexol |
[1] D01817 D01817 💬 |
- |
- |
067 [1] 67 💬 |
121 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
122 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
123 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
124 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
125 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
126 |
L-citrulline and metformin & l-citrulline |
Citrulline |
[3] D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 [1] 113 💬 |
127 |
Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
128 |
Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
129 |
Liprotamase powder for oral solution |
- |
- |
- |
- |
299 [1] 299 💬 |
130 |
Lo-ovral oral contraceptive pills |
- |
- |
- |
- |
060 [1] 60 💬 |
131 |
Lodotra (delayed release prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
132 |
Long-circulating liposomal prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
133 |
Low dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
134 |
Maximal oral 5asa |
- |
- |
- |
- |
097 [1] 97 💬 |
135 |
Medium dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
136 |
Megadose oral methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
137 |
Meloxicam oral suspension |
Meloxicam |
[1] D00969 D00969 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
138 |
Memantine hydrochloride oral solution |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [1] 2 💬 |
139 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
140 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
141 |
Metformin (generic) |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
158 [1] 158 💬 |
142 |
Metformin 500mg |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 [1] 113 💬 |
143 |
Metformin and metformin & l-citrulline |
Citrulline |
[3] D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 [1] 113 💬 |
144 |
Metformin hcl |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
285 [1] 285 💬 |
145 |
Metformin hydrochloride |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
081 [5] 81, 158, 265, 299, 301 💬 |
146 |
Metformin treatment |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [1] 46 💬 |
147 |
Metformin/cp-690,550 |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [1] 46 💬 |
148 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
149 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
150 |
Methylprednisolone or prednisolone |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
151 |
Metoprolol tartrate oral tablet |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
226 [1] 226 💬 |
152 |
Microgynon® 30 (oral contraceptive) |
- |
- |
- |
- |
046 [1] 46 💬 |
153 |
Mirdametinib (pd-0325901) oral capsule or dispersible tablet |
PD-0325901 |
- |
- |
- |
034 [1] 34 💬 |
154 |
Modified oral glucose tolerance test (50g 4-hours) |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
155 |
Mono-therapy with sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
156 |
Multi-modal pain management [fentanyl] |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
157 |
Mycophenolate mofetil orally 1000 mg twice a day (bid) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
222 [1] 222 💬 |
158 |
Naproxen oral suspension |
Naproxen |
[1] D00118 D00118 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
159 |
Neoral oral solution |
- |
- |
- |
- |
269 [1] 269 💬 |
160 |
Nilotinib 150mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
161 |
Nilotinib 300mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
162 |
Nitazoxanide 500mg oral tablet |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
163 |
Noxafil - 40 mg/ml sospensione orale uso orale flacone (vetro) 105 ml 1 flacone |
- |
- |
- |
- |
299 [1] 299 💬 |
164 |
Noxafil - oral suspension 40 mg/ml |
- |
- |
- |
- |
299 [1] 299 💬 |
165 |
Noxafil 40 mg/ml oral solution |
- |
- |
- |
- |
065 [1] 65 💬 |
166 |
Oc oral solution treatment a |
- |
- |
- |
- |
006 [1] 6 💬 |
167 |
Oc oral solution treatment b |
- |
- |
- |
- |
006 [1] 6 💬 |
168 |
Oc oral solution treatment c |
- |
- |
- |
- |
006 [1] 6 💬 |
169 |
Oc oral solution treatment d |
- |
- |
- |
- |
006 [1] 6 💬 |
170 |
Oleovit d3 14.400 iu/ml oral drops, solution |
- |
- |
- |
- |
013 [1] 13 💬 |
171 |
Omadacycline oral tablet [nuzyra] |
Omadacycline |
[1] D09647 D09647 💬 |
- |
- |
299 [1] 299 💬 |
172 |
Oral |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
173 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
174 |
Oral all-trans retinoic acid (atra) |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
094 [1] 94 💬 |
175 |
Oral anticoagulant treatment |
- |
- |
- |
- |
086 [1] 86 💬 |
176 |
Oral aztreonam |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
177 |
Oral bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 [1] 51 💬 |
178 |
Oral bovine type ii collagen |
- |
- |
- |
- |
046 [1] 46 💬 |
179 |
Oral budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
180 |
Oral budesonide suspension (mb-9) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
181 |
Oral budesonide suspension (obs) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
182 |
Oral ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
183 |
Oral ciprofloxacin plus inhaled colistin |
Ciprofloxacin |
[4] D00186 D00186, D02138 D02138, D02216 D02216, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
184 |
Oral corticosteroids |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
185 |
Oral corticosteroids (ocs) |
- |
- |
- |
- |
162 [1] 162 💬 |
186 |
Oral cromolyn sodium |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
098 [1] 98 💬 |
187 |
Oral cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
188 |
Oral drops solution |
- |
- |
- |
- |
028 [1] 28 💬 |
189 |
Oral era |
- |
- |
- |
- |
086 [1] 86 💬 |
190 |
Oral erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
036 [1] 36 💬 |
191 |
Oral escitalopram |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
192 |
Oral glucose tolerance test (75g 2-hour) |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
193 |
Oral glutathione |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
299 [1] 299 💬 |
194 |
Oral ifetroban |
Ifetroban |
[1] D04500 D04500 💬 |
TBXA2R [1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [2] 51, 86 💬 |
195 |
Oral iron |
Iron |
- |
- |
- |
254 [1] 254 💬 |
196 |
Oral levodopa and carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
197 |
Oral levodopa/carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
198 |
Oral levosimendan |
Levosimendan |
[1] D04720 D04720 💬 |
PDE3A [2] PDE3A, PDE3B 💬 |
Apelin signaling pathway [11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [1] 2 💬 |
199 |
Oral lipoic acid (la) |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
200 |
Oral methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
201 |
Oral methylprednisolone 625 mg/24h x3 days |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
202 |
Oral migalastat hcl |
Migalastat |
[1] D10359 D10359 💬 |
- |
- |
019 [1] 19 💬 |
203 |
Oral nutritional supplementation |
- |
- |
- |
- |
002 [1] 2 💬 |
204 |
Oral okt3 |
- |
- |
- |
- |
097 [1] 97 💬 |
205 |
Oral pde5 inhibitors |
- |
- |
- |
- |
086 [1] 86 💬 |
206 |
Oral pednisolone |
- |
- |
- |
- |
145 [1] 145 💬 |
207 |
Oral prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [2] 49, 145 💬 |
208 |
Oral prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
251 [1] 251 💬 |
209 |
Oral prednisone 5mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
210 |
Oral probiotic |
- |
- |
- |
- |
291 [1] 291 💬 |
211 |
Oral reduced l-glutathione |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
299 [1] 299 💬 |
212 |
Oral roflumilast |
Roflumilast |
[1] D05744 D05744 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 [1] 299 💬 |
213 |
Oral scio-469 capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
214 |
Oral selexipag (uptravi) |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
215 |
Oral sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
216 |
Oral thc |
- |
- |
- |
- |
013 [1] 13 💬 |
217 |
Oral treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [2] 51, 86 💬 |
218 |
Oral treprostinil (ut-15c) sustained release tablets |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
219 |
Oral vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
094 [2] 94, 296 💬 |
220 |
Oral viscous budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
221 |
Oral viscous budesonide (ovb) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
222 |
Orally disintegrating selegiline (zelapar) |
Selegiline |
[2] D00785 D00785, D03731 D03731 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
223 |
Orfadin oral suspension 4mg/ml |
- |
- |
- |
- |
241 [1] 241 💬 |
224 |
Oseltamivir |
Oseltamivir |
[2] D00900 D00900, D08306 D08306 💬 |
- |
- |
097 [2] 97, 299 💬 |
225 |
Other: functional oral intake scale |
- |
- |
- |
- |
002 [1] 2 💬 |
226 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
227 |
Other: metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [1] 46 💬 |
228 |
Other: modified oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
065 [1] 65 💬 |
229 |
Other: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
160 [3] 160, 195, 299 💬 |
230 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
231 |
Other: oral nitric oxide testing |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
098 [1] 98 💬 |
232 |
Other: standard immune suppression, oral |
- |
- |
- |
- |
228 [1] 228 💬 |
233 |
Other: standard of care sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 [2] 90, 301 💬 |
234 |
Overencapsulated prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
235 |
Paracetamol 120mg/5ml oral suspension |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [1] 3 💬 |
236 |
Paroxetine & prednisolone |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
237 |
Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
238 |
Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
239 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
240 |
Phenylbutyrate oral tablet |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
015 [1] 15 💬 |
241 |
Pioglitazone or metformin |
Metformin |
[4] D00944 D00944, D00945 D00945, D04966 D04966, D08378 D08378 💬 |
PPARG [3] PPARG, PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [25] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway |
265 [1] 265 💬 |
242 |
Pitolisant oral tablets |
Pitolisant |
[1] D10749 D10749 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
193 [1] 193 💬 |
243 |
Pomalidomide oral product |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
227 [1] 227 💬 |
244 |
Powder for oral suspension) |
- |
- |
- |
- |
113 [1] 113 💬 |
245 |
Predinose oral |
- |
- |
- |
- |
070 [1] 70 💬 |
246 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
247 |
Prednisolone & dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
248 |
Prednisolone + mabthera |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
249 |
Prednisolone 1mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
250 |
Prednisolone 2,5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
251 |
Prednisolone 20 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
252 |
Prednisolone 40 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
253 |
Prednisolone 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 51 💬 |
254 |
Prednisolone 5 mg jenapharm |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
255 |
Prednisolone 5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
256 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
257 |
Prednisolone 5mg tablet |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
258 |
Prednisolone acetate |
Acetate |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
259 |
Prednisolone and chlorambucil |
Chlorambucil |
[9] D00266 D00266, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
260 |
Prednisolone and mycophenolate mofetil |
Mycophenolate mofetil |
[12] D00472 D00472, D00752 D00752, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
222 [1] 222 💬 |
261 |
Prednisolone and taper |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
262 |
Prednisolone labesfal |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
263 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
264 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
265 |
Prednisolone sodium succinate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
095 [1] 95 💬 |
266 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
267 |
Prednisolone tablets bp |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
268 |
Prednisolone tablets bp 1 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
269 |
Prednisolone tablets usp 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
270 |
Prednisolone-dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
271 |
Prednisolone/prednisone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
272 |
Prednisone 0,5 mg/kg orally on alternate days |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
273 |
Prednisone or prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
274 |
Prednisone/prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
275 |
Prn1008 oral tablet |
- |
- |
- |
- |
035 [1] 35 💬 |
276 |
Procedure: celiac block with triamcinolone and bupivicaine |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
277 |
Procedure: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
278 |
Pyridoxine plus prednisolone |
Prednisolone |
[10] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02179 D02179, D03301 D03301, D08454 D08454 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
279 |
Rapamune - 1 mg 100 compresse rivestite in blister uso orale |
- |
- |
- |
- |
002 [1] 2 💬 |
280 |
Rapamune 1 mg/ml solución oral |
- |
- |
- |
- |
158 [1] 158 💬 |
281 |
Raxone - 150 mg- compresse rivestite con film- uso orale- flacone (hdpe)- 180 compresse |
- |
- |
- |
- |
113 [1] 113 💬 |
282 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
283 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
284 |
Revatio 10 mg/ml powder for oral suspension |
- |
- |
- |
- |
086 [1] 86 💬 |
285 |
Revatio oral |
- |
- |
- |
- |
086 [1] 86 💬 |
286 |
Rifaximin oral tablet |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
099 [1] 99 💬 |
287 |
Rigosertib oral capsules / rigosertib intravenous |
Rigosertib |
[1] D10154 D10154 💬 |
PLK1 [1] PLK1 💬 |
Cell cycle [4] Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
036 [1] 36 💬 |
288 |
Riluzole oral soluble film |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [1] 2 💬 |
289 |
Riluzole oral soluble film (rosf) 50 mg |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [1] 2 💬 |
290 |
Riociguat granules 0.3% for oral application |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
291 |
Riociguat oral product |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
292 |
Riociguat oral tablet |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
088 [1] 88 💬 |
293 |
Risedronate oral tablet |
Risedronic acid |
[3] D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 [1] 274 💬 |
294 |
Roflumilast oral tablet |
Roflumilast |
[1] D05744 D05744 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 [1] 299 💬 |
295 |
Ropinirole oral product |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
296 |
Rufinamide oral suspension |
Rufinamide |
[1] D05775 D05775 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
144 [1] 144 💬 |
297 |
Sabril granules for oral use |
- |
- |
- |
- |
145 [1] 145 💬 |
298 |
Saccharomyces boulardii oral tablet |
- |
- |
- |
- |
051 [1] 51 💬 |
299 |
Sb-681323 oral tablets |
- |
- |
- |
- |
046 [1] 46 💬 |
300 |
Semi continuous intra-oral administration of ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
301 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
302 |
Sildenafil (50 mg) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
303 |
Sildenafil (acute-1 hour) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
304 |
Sildenafil (as citrate) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
305 |
Sildenafil (revatio) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
306 |
Sildenafil (revatio) 20 mg tid |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
307 |
Sildenafil (subchronic-4 weeks) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
308 |
Sildenafil 20 mg tablets |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
278 [1] 278 💬 |
309 |
Sildenafil 20mg |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
310 |
Sildenafil 20mg and bosentan 62.5mg |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
311 |
Sildenafil 40mg oral capsule |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
312 |
Sildenafil and losartan |
Losartan |
[4] D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 [2] AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
313 |
Sildenafil by injection |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
210 [1] 210 💬 |
314 |
Sildenafil citrate |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [4] 51, 85, 86, 225 💬 |
315 |
Sildenafil citrate (uk-92,480) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
316 |
Sildenafil filmtabletten |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
317 |
Sildenafil singly or in association with bosentan |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
318 |
Sildenafil therapy |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
319 |
Simvastatin 20mg/5ml oral suspension |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
034 [1] 34 💬 |
320 |
Sirolimus oral liquid product 1mg/ml |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
278 [1] 278 💬 |
321 |
Sirolimus oral product |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [2] 89, 158 💬 |
322 |
Sitagliptin and metformin |
Metformin |
[3] D00944 D00944, D04966 D04966, D08516 D08516 💬 |
DPP4 [3] DPP4, PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [20] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway |
233 [1] 233 💬 |
323 |
Sitaxsentan and sildenafil |
Sildenafil |
[3] D02229 D02229, D07171 D07171, D08514 D08514 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
324 |
Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth |
Dextrose, unspecified form |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
325 |
Soluble prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
326 |
Sporanox 10 mg/ml oral solution |
- |
- |
- |
- |
299 [1] 299 💬 |
327 |
Standard analgesia use [fentanyl] |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
328 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
329 |
Sustained-release oral dalfampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
330 |
Tadalafil and sildenafil |
Sildenafil |
[3] D02008 D02008, D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 [1] 113 💬 |
331 |
Tadalafil oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
332 |
Tadalafil- tablet or oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
333 |
Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. |
Teicoplanin |
[1] D02142 D02142 💬 |
- |
- |
299 [1] 299 💬 |
334 |
Teriflunomide 14 mg oral tablet [aubagio] |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
335 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
336 |
Tizanidine (sublingual or oral) |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
337 |
Tofacitinib 5mg oral tablet [xeljanz] 16 week trial |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
084 [1] 84 💬 |
338 |
Tolvaptan oral tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
339 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
[3] D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 [6] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
340 |
Translarna 1000 mg granules for oral suspension |
- |
- |
- |
- |
113 [1] 113 💬 |
341 |
Translarna 125 mg granules for oral suspension |
- |
- |
- |
- |
113 [1] 113 💬 |
342 |
Translarna 250 mg granules for oral suspension |
- |
- |
- |
- |
113 [1] 113 💬 |
343 |
Trazodone hydrochloride oral solution |
Trazodone |
[2] D00820 D00820, D08626 D08626 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
002 [1] 2 💬 |
344 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
345 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
346 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
347 |
Triamcinolone 40 milligrams (kenacort, bristol myers squip) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
348 |
Triamcinolone acetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [3] 35, 46, 56 💬 |
349 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
350 |
Triamcinolone hexacetonid (lederspan) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
351 |
Triamcinolone hexacetonide |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
352 |
Triamcinolone hexacetonide (lederspan) |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
353 |
Vamorolone 4% suspension for oral dosing |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
354 |
Ventoline oral solution 0,4mg/ml |
- |
- |
- |
- |
111 [1] 111 💬 |
355 |
Vfend 40 mg/ml powder for oral suspension |
- |
- |
- |
- |
299 [1] 299 💬 |
356 |
Vigabatrin |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [2] 145, 158 💬 |
357 |
Vigabatrin (sabril) |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
158 [1] 158 💬 |
358 |
Vigabatrin tablets |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
359 |
Vigabatrin: vigabatrin new st formulation then sabril® |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
360 |
Z102 (prednisolone and dipyridamole). |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |